ABVC BioPharma utilizes in-licensed technology from research institutions, including Cedars-Sinai Medical Center.
2 reports, 1 independent
Updated Aug 6
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
ABVC BioPharma utilizes in-licensed technology from research institutions, including Cedars-Sinai Medical Center.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cedars-Sinai Medical Center
hospital in Los Angeles, California, United States
Coverage
Newest first; wire copies grouped- NewMediaWireABVC BioPharma Gains Confidence From International Investors to Support Growth Path SILICON VALLEY, CA - August 6, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-st
- Unknown outlet